Steve Trattner discovered the property that would become Erin Hills. Then he was convicted of a murder of which no one ...

One team principal agrees, with Haas team boss Ayao Komatsu revealing his drivers, Oliver Bearman and Esteban Ocon, would’ve been told “no” as he wants their full attention on F1.

The treatment, described in a new study published in The New England Journal of Medicine and presented at the American Society of Gene and Cell Therapy meeting, relies on a complex therapy known ...

New York Knicks star point guard Jalen Brunson is the league's Clutch Player of the Year. That means when the moments are the biggest, he shines the most, but that wasn't the case in the Knicks ...

Haas boss Ayao Komatsu believes its new multi-million dollar motorhome "sends a clear message" of intent from owner Gene Haas. As teams again bring their motorhomes to circuits, with the European leg ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new ...

Cadillac are set to become the first new team to enter Formula 1 next season since Haas’ introduction nearly 10 years ago. Haas were led onto the grid at the 2016 Australian Grand Prix by team ...

Now reunited at Haas, Ocon affirms Komatsu's unwavering competitiveness, highlighting their shared drive. The Moneygram Haas F1 team has put on a commendable performance so far in the 2025 season ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, co-founder ... is designed to simplify gene editing tech and overcome ...

Clint Eastwood, Morgan Freeman, Nathan Lane, and more remember Gene Hackman: 'One of the all time greatest' Morgan Freeman leads Oscars 'In Memoriam' with Gene Hackman tribute, plus Gena Rowlands ...

One of the worst teams in baseball history had the worst night in franchise history Saturday. The Colorado Rockies got blown out by the San Diego Padres at Coors Field (SD 21, COL 0) for their ...

Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug (casdozo, SRF388) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients ...